Telomir Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:TELO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
13 Feb 24	BuyUS$343,000	Brian McNulty	Individual		49,000	US$7.00
13 Feb 24	BuyUS$623,000	Bayshore Trust	Company		89,000	US$7.00

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: TELO only recently listed within the past 12 months

Top 18 shareholders own 44.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23%	Bayshore Trust	6,821,076	US$34.2m	26.2%	no data
7.16%	Francis O’Donnell	2,119,220	US$10.6m	8.61%	no data
6.51%	Brian McNulty	1,927,050	US$9.7m	2.61%	no data
3.29%	Christopher Chapman	975,610	US$4.9m	0%	no data
1.65%	James McNulty	487,805	US$2.4m	0%	no data
1.65%	Craig Eagle	487,805	US$2.4m	0%	no data
0.34%	Nathen Fuentes	101,134	US$507.7k	0%	no data
0.16%	Hugh McColl	48,781	US$244.9k	0%	no data
0.16%	Bradley Kroenig	48,781	US$244.9k	0%	no data
0.16%	Talhia Tuck	48,781	US$244.9k	0%	no data
0.082%	Suncoast Equity Management, LLC	24,391	US$122.4k	0%	0.02%
0.06%	Citigroup Inc.,Banking and Securities Investments	17,748	US$89.1k	0%	no data
0.051%	Lido Advisors, LLC	15,000	US$75.3k	0%	no data
0.05%	FNY Investment Advisers, LLC	14,900	US$74.8k	0%	0.06%
0.03%	Geode Capital Management, LLC	8,951	US$44.9k	-3.32%	no data
0.016%	Beaird Harris Wealth Management, LLC	4,673	US$23.5k	0%	no data
0.0088%	JPMorgan Chase & Co, Brokerage and Securities Investments	2,605	US$13.1k	0%	no data
0.002%	Arbor Point Advisors, LLC	600	US$3.0k	0%	no data